|
|
(Journal Article): Localization and Expression of CCR3 and CCR5 by Interleukin-1? in the RIN-5AH Insulin-Producing Model System: A Protective Mechanism Involving Down-Regulation of Chemokine Receptors
Vassiliadis S, Balabanidou V, Papadopoulos GK, Athanassakis I (Laboratory of Immunology, Department of Biology, University of Crete. Heraklion, Crete, Greece,
simon@biology.uoc.gr
)
IN:
JOP. J Pancreas (Online)
2002; 03(3):66-75
Fulltext:
HTML
PDF
ABSTRACT: CONTEXT AND OBJECTIVE: The inflammatory cytokine interleukin-1beta has been considered to be an immune effector molecule in insulin dependent diabetes mellitus. As such, we examined its role on chemokine receptors which, when expressed in the pancreas, have also been associated with the development of type I autoimmune diabetes. DESIGN AND MAIN OUTCOME MEASURES: The presence of membrane and cytoplasmic levels of CCR3 and CCR5 expression is assessed by immunofluorescence in control and interleukin-1beta-treated RIN-5AH cells. The cytoplasmic expression is also shown by confocal microscopy as assessed by the brightness of the cells whereas enzyme-linked immunosorbent assay detects secreted CCR3 and CCR5 molecules by comparing optical density values as these derive from the control and the treated cells. Cell-fractionation experiments show the exact location of the intracellular pools of the chemokine receptors by using the rab7 monoclonal antibody as a guiding molecule. RESULTS: Interleukin-1beta down-regulates constitutively expressed surface CCR3 and CCR5 levels implying receptor internalization for re-utilization or destruction, secretion or both. Cytoplasmic immunofluorescence and confocal microscopy demonstrate cellular retention of chemokine receptors by interleukin-1beta which may be released in the absence of interleukin-1beta as assessed by enzyme-linked immunosorbent assay. Finally, cell-fractionation shows the presence of both receptors in endosomes exhibiting an increasing density after interleukin-1beta treatment. CONCLUSIONS: Given the association of chemokine receptors with progression to diabetes, it appears that interleukin-1beta-induced down-regulation of CCR3 and CCR5 promotes a protective mechanism against cellular destruction. The major role of interleukin-1beta is to maintain these molecules within the endosomes. Thus, interleukin-1beta modulates the movement and the expression of constitutively expressed chemokine receptors and does not accentuate the total destructive effect suffered by the cells.
TYPE OF PUBLICATION: Original Article
|
Respond
on this Journal Article!
Hint: Your Response should directly apply to Localization and Expression of CCR3 and CCR5 by Interleukin-1? in the RIN-5AH Insulin-Producing Model System: A Protective Mechanism Involving Down-Regulation of Chemokine Receptors.
Please check, if this context applies best to your contribution. Otherwise click HERE to change to the appropriate
subject area. The actual subject area is Journal Article.
|
|
|
|
|